Biobot Analytics specializes in wastewater epidemiology, which involves analyzing sewage to gather important public health data. The company serves various clients, including governments, businesses, universities, and health systems, providing insights into community health trends such as the presence of high-risk substances and the spread of diseases. By analyzing wastewater samples, Biobot offers data analysis services that help clients make informed decisions to enhance public health efforts. Clients subscribe to Biobot's services for regular reports and real-time data, allowing them to monitor health trends in their communities. Unlike its competitors, Biobot focuses specifically on wastewater analysis, which has proven particularly useful during health crises like the COVID-19 pandemic. The company's goal is to transform wastewater infrastructure into a valuable tool for public health surveillance, ultimately improving health outcomes and equity in communities.

Plum Alley

American Family Institute

Thursday Ventures

Tom Knight

Anne Wojcicki

The Engine

DCVC

Ekistic Ventures

Forward Deployed VC

Y Combinator

Social Impact

Healthcare

BioBot Analytics

Biobot Analytics has successfully raised an impressive $30 million in its latest funding round, a significant boost that will propel the company's mission to revolutionize public health monitoring through innovative sewage analysis technology.

Biobot Analytics Secures $30 Million in Funding to Revolutionize Public Health Monitoring Through Sewer Technology

Biobot Analytics Launches Unique Nationwide Wastewater Monitoring Program

Biobot Closes $24M in Series B Funding

CAMBRIDGE, Mass., Dec. 21, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater epidemiology, announced that the company has reached full enrollment for a nationwide program sponsored by the National Institute on Drug Abuse (NIDA) to conduct anonymous, population-level wastewater-based monitoring on drugs of use and misuse, and overdose reversal agents. This is the first program of its kind in the United States and follows a design similar to that of successful programs in the European Union and Australia.In less than two months, Biobot recruited 70 wastewater treatment facilities and their associated public health departments into the program, with interest surpassing the program limit. Participants span 43 states, 62 counties representing approximately 35 million Americans, and include a diverse mix of urban and rural communities of varying sizes, ranging from San Diego, CA to Laredo, TX.While few of these communities had previously tested wastewater for high-risk substances, all of them expressed a strong interest in utilizing wastewater data to better understand and prevent substance use disorder and overdose deaths. Throughout this process, Biobot was greeted with high levels of enthusiasm for this program from local officials looking for new and innovative ways to limit the deadly impact of fentanyl and similar substances.In announcing the City of San Francisco's participation in this initiative , Dr. Hillary Kunins, SFDPH Behavioral Director, explained: "We need all the tools available to identify the presence of substances that may be used to halt and reverse this deadly epidemic

Biobot Analytics Reaches Full Enrollment For Nida-Funded Nationwide Wastewater-Based Monitoring Program For High Risk Substances

Former U.S. National Security Advisor joins Biobot to help grow its national security strategyCAMBRIDGE, Mass., Nov. 1, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater epidemiology, today announced that Lieutenant General H.R. McMaster, Former U.S. National Security Advisor, has joined the company's Board of Advisors. Lt

Lieutenant General H.R. Mcmaster Joins Biobot Analytics' Board Of Advisors

Biobot Analytics files protest against CDC issuing wastewater surveillance contract to Verily.

Biobot Analytics files protest against CDC issuing wastewater surveillance contract to Verily

It wasn't long before she met her partner, an architect, and together they went on to cofound BioBot securing over $40 million in venture capital funding.

Growing the Latinx Legacy at Winsor during Hispanic Heritage Month

/PRNewswire/ -- Biobot Analytics, a global leader in wastewater epidemiology, was awarded a Phase III Small Business Innovation Research (SBIR) contract from...

Biobot Analytics Awarded NIDA Funding for Nationwide Wastewater-Based Monitoring Program for High Risk Substances and Others Associated with Health Risks

The Respiratory Illnesses Panel will include monitoring for Influenza A and B, RSV, and SARS-CoV-2CAMBRIDGE, Mass., Aug. 24, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater intelligence, announced today that it is launching a Respiratory Illnesses Panel that will include concurrent wastewater monitoring for Influenzas A and B (seasonal flu), Respiratory Syncytial Virus (RSV), and SARS-CoV-2 (COVID-19).Last year, the "tripledemic" of influenza, RSV, and COVID-19 overwhelmed the U.S. healthcare system, and nearly 40 percent of U.S. households reported experiencing at least one of these respiratory illnesses in January. COVID-19 was associated with approximately 244,000 deaths in the U.S. in 2022, and the 2022-2023 flu season caused an estimated 19,000-57,000 deaths in the U.S., per CDC

Biobot Analytics Launches Respiratory Illnesses Panel

This latest development continues to expand Biobot's Infectious Disease platformCAMBRIDGE, Mass., April 19, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater intelligence, announced today that it is expanding its infectious disease platform to include wastewater monitoring for norovirus. As the leading cause of foodborne illness in the United States, the highly contagious norovirus costs the economy approximately $2 billion annually in lost productivity and healthcare expenses, with over 20 million illnesses every year.Over recent years, wastewater monitoring has become an increasingly valuable tool for monitoring the spread of infectious diseases within populations, as well as for detecting the use of high-risk substances such as opioids. Biobot's wastewater intelligence platform enables early warning health analytics to combat epidemics and improve public health outcomes across the world."Norovirus rates continue to be at a yearly high across the country. Wastewater monitoring provides equitable and inclusive data that can help public health officials prepare and respond more effectively to outbreaks," said Mariana Matus, CEO of Biobot Analytics. "Currently, the CDC doesn't require norovirus case reporting, so we are relying on a subset of voluntarily provided data, resulting in larger knowledge gaps about levels of disease than with other pathogens. By monitoring wastewater for norovirus, we can begin to fill in these gaps and provide important information about disease levels and trends, so communities can make informed public health decisions."The addition of norovirus to Biobot's wastewater epidemiology platform builds on the company's continuous efforts to transform wastewater infrastructure into real-time public health observatories

Biobot Analytics To Begin Wastewater Monitoring For Norovirus

Analyzes wastewater for public health insights

BioBot Analytics

Analyzes wastewater for public health insights

BioBot Analytics

Analyzes wastewater for public health insights

About

Simplify's Take

What believers are saying

What critics are saying

What makes BioBot Analytics unique

6 month growth

1 year growth

2 year growth

Benefits

Recently Posted Jobs

There are no jobs for BioBot Analytics right now.